Zika Virus Therapeutics Market Worth USD 33.21 Million


Posted July 19, 2019 by ruchiwalt

Technavio Research Report "Zika Virus Therapeutics Market by product (acetaminophen, and other NSAIDs) and geographic regions (ROW, North America, Asia, and Europe) is witnessed to grow USD 33.21 million

 
Global Zika Virus Therapeutics Market: Novel approach for vaccine development

Various novel approaches are being developed to treat the chronic health conditions occurring due to the Zika virus. Vendors in the market are developing vaccines with modified RNA activity. These vaccines consist of a lipid capsule encapsulating nanoparticle which is administered through the intramuscular route. They also contain a modified messenger RNA (mRNA), which is non-self-amplifying and optimizes the intracellular stability, translation, and proprietary nucleoside alteration to prevent the stimulation of innate immune response. Another vaccine developed contains modified nucleoside 1-methylpseudouridine, which increases the translation of mRNA. These newly developed vaccines are targeted at producing a high concentration of antibodies against Zika virus infection. Thus, the development of RNA vaccines against Zika virus is likely to pave the way for other researchers to facilitate further R&D in this area.

Global Zika Virus Therapeutics Market: Segmentation analysis

This market research report segments the global Zika virus therapeutics market by product (acetaminophen, and other NSAIDs) and geographic regions (ROW, North America, Asia, and Europe).

ROW led the market in 2018, followed by North America, Asia, and Europe respectively. The region is expected to grow faster than the overall market owing to increasing instances of this medical condition.

Global Zika Virus Therapeutics Market: Rising prevalence of and burden of Zika virus

Zika virus infection gradually has witnessed several outbreaks reported from various parts of the world. It is transmitted by infected mosquitos and results in non-specific symptoms, including fever, myalgia, and generalized fatigue. The market is witnessing a high incidence of the Zika virus, which is expected to increase the patient pool leading to increased consumption of Zika virus therapeutics. Thus, the growing prevalence and burden of Zika virus infection and associated comorbidities will foster market growth during the forecast period.

https://www.technavio.com/report/global-zika-virus-therapeutics-market-industry-analysis
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Ruchi Walt
Country United States
Categories Blogging
Tags httpswwwtechnaviocomreportglobalzikavirustherapeuticsmarketindustryanalysis
Last Updated July 19, 2019